Lexicon Pharmaceuticals | LXRX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Abbott USD 158.05B 20.36B 2026-06
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
AstraZeneca USD 178.16B 111.83B 2026-08
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.11T 18.32B 2026-08
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Illumina USD 26.71B 8.84B 2026-06
Insmed USD 19.68B 3.43B 2026-08
J&J USD 611.36B 32.21B 2026-06
Lexicon Pharmaceuticals USD 418M 73M 2025-12
MacroGenics USD 184M 82M 2026-03
MannKind USD 1.11B 207M 2026-08
Merck USD 324.18B 6.81B 2026-08
Novartis USD 240.59B 67.17B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
Thermo Fisher Scientific USD 190.65B 7.99B 2026-06
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
United Therapeutics USD 24.42B 1.42B 2026-08
Vanda Pharmaceuticals USD 279M 6M 2024-12